Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-19

  1. 12,774 Posts.
    lightbulb Created with Sketch. 2600
    what a crap register we have!

    back to where we started...lol

    You have NYR at pre-clinical and trading at $26m MC and up 16% today on nothing!!

    Then you have 1AD at only $15m MC and will be heading into phase 2 clinical trials in the near future.

    This is absolute madness imo.
    Last edited by TopGun1: 08/04/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $3.338M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
25 24907277 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 13636800 15
View Market Depth
Last trade - 16.21pm 08/08/2025 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.